Candidate antigens for a ductal carcinoma in situ vaccine, essential for breast cancer cell survival across multiple subtypes, are immunogenic in DCIS and IBC
Document Type
Presentation
Publication Date
9-9-2022
Keywords
oregon; portland; chiles; genomics
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
Comments
AACR Annual Meeting; 2022 September 9; Philadelphia, PA.